Filing Details
- Accession Number:
- 0001683168-20-000840
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2020-03-16 19:17:48
- Reporting Period:
- 2020-03-13
- Accepted Time:
- 2020-03-16 19:17:48
- Original Submission Date:
- 2020-03-13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1226616 | Medicinova Inc | MNOV | Pharmaceutical Preparations (2834) | 330927979 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1531140 | Kazuko Matsuda | C/O Medicinova, Inc. 4275 Executive Square, Suite 300 La Jolla CA 92037 | Chief Medical Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-03-13 | 2,000 | $3.62 | 111,746 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The reported shares were purchased in multiple transactions. The purchase price reported in Column 4 is a weighted average price ranging from $3.54 to $3.69. The reporting person undertakes to provide to MediciNova, Inc., any security holder of MediciNova, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- Includes 289 shares acquired under MediciNova's employee stock purchase plan, which are exempt under Rule 16b-3(c).
- This report is being amended to correct the amount of securities beneficially owned in Column 5.
Billionaire Hedge Funds
